Predicting 15-Year Mortality in Adults With Congenital Heart Disease Using Disease Severity and Functional Indices

Fouke Ombelet1, Eva Goossens2, Silke Apers1

  • 1KU Leuven Department of Public Health and Primary Care, KU Leuven - University of Leuven, Leuven, Belgium.

Insights

The Congenital Heart Disease Functional Index (CHDFI) best predicts 15-year mortality in adults with congenital heart disease (CHD). This index, incorporating both anatomic and physiological factors, offers superior risk stratification compared to other common indices.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Public Health

Background:

  • Congenital heart disease (CHD) affects adults, requiring long-term risk stratification.
  • Current disease severity and functional indices are used for risk stratification, but their long-term predictive value for mortality is not well-established.
  • Assessing long-term mortality risk is crucial for managing adult CHD patients.

Purpose of the Study:

  • To determine and compare the predictive value of various disease severity and functional indices for 15-year mortality in adults with CHD.
  • To identify the most effective index for risk stratification in this population.

Main Methods:

  • A cohort of 629 adult CHD patients (median age 24 years) were assessed using five indices: Task Force 1 criteria, Disease Severity Index, New York Heart Association functional class, Ability Index, and Congenital Heart Disease Functional Index (CHDFI).
  • Cox hazard regression analysis and Harrell's concordance statistics index (C-index) were used to evaluate the predictive performance of each index for all-cause and cardiac mortality over 15 years.

Main Results:

  • Over 15 years, 40 deaths occurred (4.56 per 1000 person-years).
  • The CHDFI demonstrated the highest predictive ability for all-cause mortality (C-index = 0.74) and cardiac mortality (C-index = 0.76).
  • The CHDFI showed statistically superior discrimination compared to the Disease Severity Index (P < 0.01).

Conclusions:

  • Several indices, including Task Force 1, NYHA class, Ability Index, and CHDFI, can aid in predicting long-term mortality in adults with CHD.
  • The CHDFI's superior performance highlights the importance of integrating both anatomic and physiological variables for accurate long-term mortality prediction.
  • The CHDFI is a valuable tool for risk stratification in adult CHD patients.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
464
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
303
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
288
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
523
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
987